Diagnosis of cytomegolovirus;Neue methoden in der zytomegalievirus-diagnostik

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 27, 2004, Pages 1509-1512

  Preiser, W ^a   Fleckenstein, C ^a   Doerr, H W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR; VALGANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENCEPHALITIS; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LABORATORY TEST; MYOCARDITIS; PERSISTENT VIRUS INFECTION; PNEUMONIA; RETINITIS; REVIEW; SEROPREVALENCE; VIRUS DIAGNOSIS; VIRUS REPLICATION;

AGE DISTRIBUTION; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GENOME, VIRAL; HUMANS; RISK FACTORS; RNA, MESSENGER;

EID: 3042834248     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-826894     Document Type: Review

References (15)

1. Berger A, Preiser W. Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. J Antimicrob Chemother 2002; 49: 713-721
2. de Jong MD, Boucher CA, Danner SA et al. Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections. Antiviral Res 1998; 37: 1-16
3. Einsele H, Hebart H, Brock T et al. Empfehlung zur Diagnostik und Therapie der Zytomegalievirus-Infektion nach Stammrell-Transplantationen. Dtsch Med Wochenschr 1999; 124: 501-506
4. Fleckenstein C, Doerr HW, Preiser W. Quantifizierung von CMV-DNA als diagnostisches Werkzeug zur verbesserten Behandlung und Überwachung von Risikopatienten. J Lab Med 2002; 26: 486-494
5. Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001; 357: 513-518
6. Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W. Primary cytomegalovirus infection in an outpatient setting - laboratory markers and clinical aspects. Infection 2003; 31: 318-323
7. Kaiser L, Perrin L, Chapuis B et al. Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay. J Clin Microbiol 2002; 40: 4251-4255
8. Kem F, Faulhaber N, Khatamzas E et al. Measurement of anti-human cytomegalovirus T cell reactivity in transplant recipients and its potential clinical use: a mini-review. Intervirology 1999; 42: 322-324
9. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097
10. Preiser W, Brink NS, Ayliffe U et al. Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma. J Clin Virol 2003a; 26: 49-59
11. Preiser W, Buxbaum S, Fleckenstein C, Doerr HW. Measurement of CMV DNA Levels and CMV-Specific CD4+ Lymphocyte Counts in Patient Specimens: Requirements for Test Quality and Practicability in a Routine Diagnostic Service. Basel: Karger, In: Prösch S, Cinatl J, Scholz M (eds): New Aspects of CMV-Related Immunopathology. Monographs in Virology. 2003b; vol. 24
12. Reesink HW, Engelfriet CP, Tegtmeier GE et al. Prevention of post-transfusion cytomegalovirus: leucoreduction or screening? Vox Sang 2002; 83: 72-87
13. Sester M, Sester U, Gärtner B et al. Sustained high frequencies of specific CD4T cells restricted to a single persistent virus. J Virol 2002; 76: 3748-3755
14. Tedder RS, Ayliffe U, Preiser W et al. Development and evaluation of an internally controlled semiautomated PCR assay for quantification of cell-free cytomegalovirus. J Med Virol 2002; 66: 518-523
15. Weber B, Nestler U, Ernst W et al. Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients. J Med Virol 1994; 43: 187-193